parp inhibitors for prostate cancer with moshe ornstein, md
Published 3 years ago • 290 plays • Length 9:53Download video MP4
Download video MP3
Similar videos
-
1:43
parp inhibitors for prostate cancer
-
30:37
kidney cancer patient expert q&a: dr. moshe ornstein
-
2:12
cleveland clinic hematology & medical oncology fellowship program testimony with dr. ornstein
-
2:29
dr. ornstein on challenges with immunotherapy in rcc
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
1:10:43
urowebinar: parp inhibitors in prostate cancer part 2
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
4:12
parp inhibitors
-
40:21
parp inhibitors in advanced prostate cancer care
-
4:02
the emerging role of parp inhibitors in prostate cancer
-
3:31
hampered by hormones
-
38:47
parp inhibitors and their evolving role for the treatment of prostate cancer
-
1:08
the role of parp inhibitors in prostate cancer
-
35:38
parp inhibitor combination regimens for prostate cancer management
-
59:38
prostate cancer survivorship | virtual event
-
1:32
dr. hussain discusses parp inhibitors in prostate cancer
-
2:30
parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
-
1:58
dr. george on promise of parp inhibitors in prostate cancer
-
1:00
dr. morgan discusses the impact of parp inhibitors in prostate cancer
-
0:52
dr. morgan on combinations with parp inhibitors in prostate cancer
-
7:18
updates in parp inhibition and germline testing in prostate cancer